Show simple item record

dc.contributor.authorGöker, Erdem
dc.date.accessioned2021-05-05T09:16:34Z
dc.date.available2021-05-05T09:16:34Z
dc.date.submitted1995
dc.date.issued2018-08-06
dc.identifier.urihttps://acikbilim.yok.gov.tr/handle/20.500.12812/581483
dc.description.abstract
dc.description.abstracten_US
dc.languageTurkish
dc.language.isotr
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsAttribution 4.0 United Statestr_TR
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectEndokrinoloji ve Metabolizma Hastalıklarıtr_TR
dc.subjectEndocrinology and Metabolic Diseasesen_US
dc.subjectOnkolojitr_TR
dc.subjectOncologyen_US
dc.titleEdinilmiş methotrexate direnç mekanizması olarak dihidrofolat reduktaz gen amplifikasyonu ve p53 tümör baskılayıcı gen mutasyonları ile ilişkisi
dc.typedoctoralThesis
dc.date.updated2018-08-06
dc.contributor.departmentDiğer
dc.subject.ytmPrecursor cell lymphoblastic leukemia-lymphoma
dc.subject.ytmGene amplification
dc.subject.ytmMutation
dc.subject.ytmMethotrexate
dc.subject.ytmTetrahydrofolate-dehydrogenase
dc.subject.ytmGenes-P53
dc.identifier.yokid40082
dc.publisher.instituteTıp Fakültesi
dc.publisher.universityDOKUZ EYLÜL ÜNİVERSİTESİ
dc.type.submedicineThesis
dc.identifier.thesisid40082
dc.description.pages30
dc.publisher.disciplineDiğer


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/embargoedAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/embargoedAccess